We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

BIOVENDOR

BioVendor Instruments a.s. is involved in research & development related to automation and optimization of processes ... read more Featured Products: More products

Download Mobile App





BioVendor Presents Latest Innovations in Immunodiagnostics and Molecular Diagnostics at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023
Print article
Image: The KleeYa fully automated CLIA solution (Photo courtesy of BioVendor)
Image: The KleeYa fully automated CLIA solution (Photo courtesy of BioVendor)

BioVendor Group (Brno, Czech Republic) is demonstrating its latest innovations in immunodiagnostics and molecular diagnostics at Medlab Middle East 2023.

At this year’s Medlab Middle East, BioVendor is presenting its growing CLIA portfolio of parameters, Microblot-Array multiplex diagnostics in microtiter plate format, other technologies, such as the revolutionary NGS technology fastGEN, and its unique methods using microRNAs. BioVendor is highlighting its CLIA portfolio of assays with a constantly growing number of parameters developed for the cutting-edge analyzer KleeYa. BioVendor Group’s CLIA portfolio currently includes 41 unique parameters. Its MxA Human Protein is the flagship of a total of 41 unique CLIA parameters that expand the possibilities of laboratories.

BioVendor is also highlighting Microblot-Array (MBA), a new generation of unique, immunoblot array in a microtiter plate format. It is designed for efficient multiplex diagnostics, enabling the simultaneous detection of multiple markers which can save time and lower costs. The Microblot-Array is a comprehensive solution for fast and accurate multiplex diagnostics. A combination of BLOT principle and ELISA workflow allows the use of existing laboratory equipment and keeps the setup costs down.

At Medlab Middle East 2023, BioVendor is showcasing its new technology fastGEN for examination of the mutation status of oncomarkers in samples. The technology is base on ultra-deep sequencing of short amplicons obtained by a single polymerase chain reaction with special tagged hybrid primers. The fastGEN technology is simple, ultra-sensitive, specific and effective - it is perfectly adapted to diagnostics and offers new advantages for clinical material. BioVendor highlighted its user-friendly diagnostic kits with software solution for KRAS, NRAS, BRAF, EGFR, IDH 1/2, POLE and CFTR genes with excellent analytical parameters and extremely fast processing.

Additionally, BioVendor is demonstrating its complete solution for miRNA/sncRNA projects starting with isolation, followed by screening for proper targets and final quantification of them. The small regulatory molecules, called microRNA or miRNA, have become emerging biomarkers for research in all fields of medical and biological sciences. This new miRNA regulatory domain empowers R&D, identifies novel disease biomarkers in biofluids and tissues and develops non-invasive screening and diagnostic tests. Using miRNA as pathological biomarkers is technically feasible, highly specific and sensitive from the earliest stages of the disease. BioVendor offers specific technologies based on patented RT-qPCR for sensitive detection and quantification of miRNA molecules. The technologies use multiplex detection format already used in life sciences research and clinical diagnostic applications.

Related Links:
BioVendor Group 

Gold Supplier
STI Real-Time PCR Test
Neisseria Gonorrhoeae/Chlamydia Trachomatis/U.urealyticum Real-Time PCR Kit
New
Infection Laboratory Test Panels
Synovasure
New
Laboratory Balance
Equinox Precision
New
Free Triiodothyronine (fT3) Rapid Test
Finecare fT3 Rapid Quantitative Test

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: The new assay enables accurate prognosis and detection data for those prone to esophageal cancer (Photo courtesy of Previse)

First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer

Esophageal cancer is among the most lethal cancers in the world and has a 20% five-year survival rate post-diagnosis. Barrett's esophagus is the sole precursor known and is a significant risk factor for... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more

Pathology

view channel
Image: Artificial intelligence predicts genetics of cancerous brain tumors in under 90 seconds (Photo courtesy of Michigan Medicine)

AI-Based Diagnostic Screening System Predicts Genetics of Cancerous Brain Tumors in 90 Seconds

The diagnosis and treatment of gliomas increasingly rely on molecular classification, as surgical benefits and risks vary depending on a patient's genetic makeup. Complete removal of the tumor can extend... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel (Photo courtesy of Roche)

Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's

Presently, obstacles to timely and precise diagnosis of Alzheimer's disease exist globally, resulting in as many as 75% of individuals exhibiting symptoms but lacking a formal diagnosis.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.